Respiratory diseases are a challenging problem to treat. Inhalable medicines are a promising solution that depends on the ...

A multimodal, digital community-based intervention was feasible and decreased illness-related distress in treating patients ...

Patients with COPD had better inhaler adherence when invited to enroll in a program that lowers cost sharing for maintenance ...

People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...

Chronic obstructive pulmonary disease (COPD) is a significant global health concern, ranking as the third-leading cause of mortality worldwide and affecting around 480 million people. 1,2 Its hallmark ...

Chronic obstructive pulmonary disease (COPD) is a heterogeneous respiratory condition characterized by symptoms of dyspnea, cough, and sputum production. We review sex-differences in disease ...

Chronic obstructive pulmonary disease (COPD) is an irreversible inflammatory disease of the lungs that makes it more difficult to breathe over time. The disease causes changes to the tissues inside ...

While no cure currently exists for COPD, several types of medication can often reduce symptom severity. Steroids are among the medications commonly prescribed to treat COPD. They help reduce the ...

The authors surveyed nearly 350 people about how many attempts it took to quit a substance before they were finally able to maintain their sobriety - revealing which drugs could be the most addicting.

Criticism over how the Chinese government buys drugs for its public health care system has ignited frustration over the quality of medicine. By Alexandra Stevenson and Zixu Wang Reporting from ...

It’s time to move on from treating heroin as Europe’s main drug problem, according to the head of the European Union’s drugs agency. That’s not to say heroin isn’t still a major problem.